The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus

被引：1
|
作者：
Kramer, Jennifer R. [1 ,2 ]
Richardson, Peter A. [1 ,2 ]
Kim, Hyunseok [3 ]
Hsu, Yao-Chun [4 ,5 ]
Kanwal, Fasiha [1 ,3 ]
El-Serag, Hashem B. [1 ,3 ,6 ]
机构：
[1] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA
[2] Baylor Coll Med, Dept Med, Hlth Serv Res, Houston, TX USA
[3] Baylor Coll Med, Sect Gastroenterol & Hepatol, Hlth Serv Res, Dept Med, Houston, TX USA
[4] E Da Hosp Kaohsiung, Ctr Liver Dis, Kaohsiung, Taiwan
[5] E Da Hosp Kaohsiung, Div Gastroenterol, Hepatol Fu Jen Catholic Univ Hosp, Kaohsiung, Taiwan
[6] Baylor Coll Med, Sect Gastroenterol & Hepatol, 7200 Cambridge St, Houston, TX 77030 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 04期
关键词：
PROPENSITY SCORE METHODS;
D O I：
10.1016/j.cgh.2022.02.056
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1111 / 1113
页数：3
相关论文
共 50 条
  • [1] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B
    Choi, Won-Mook
    Choi, Jonggi
    Wong, Grace Lai-Hung
    Han, Seungbong
    Lim, Young-Suk
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 87
  • [2] No difference in hepatocellular carcinoma risk between chronic hepatitis B patients treated with entecavir versus tenofovir
    Su, Feng
    Berry, Kristin
    Ioannou, George N.
    [J]. GUT, 2021, 70 (02) : 370 - 378
  • [3] ENTECAVIR VS. TENOFOVIR ON THE RISK OF HCC IN A US COHORT WITH CHRONIC HEPATITIS B VIRUS
    El-Serag, Hashem B.
    Richardson, Peter A.
    Kim, Hyun-Seok
    Hsu, Yao-Chun
    Kanwal, Fasiha
    Kramer, Jennifer
    [J]. HEPATOLOGY, 2021, 74 : 43A - 43A
  • [4] Comparative Effectiveness of Tenofovir vs. Entecavir in Reducing the Risk of Hepatocellular Carcinoma in a US Cohort of Patients with Chronic Hepatitis B Virus Infection
    Kramer, Jennifer R.
    Mittal, Sahil
    Richardson, Peter
    El-Serag, Hashem B.
    Kanwal, Fasiha
    [J]. HEPATOLOGY, 2015, 62 : 335A - 336A
  • [5] COMPARATIVE EFFECTIVENESS OF TENOFOVIR VS. ENTECAVIR IN REDUCING THE RISK OF HEPATOCELLULAR CARCINOMA IN A US COHORT OF PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
    Kramer, Jennifer R.
    Kim, Hyunseok
    Christie, Israel
    Richardson, Peter
    El-Serag, Hashem B.
    Kanwal, Fasiha
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1320 - S1320
  • [6] Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Lee, Han Ah
    Seo, Yeon Seok
    Kim, Seung Up
    [J]. GASTROENTEROLOGY, 2020, 158 (08) : 2310 - 2311
  • [7] Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir
    Chang, Jin Won
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Seo, Yeon Seok
    Lee, Han Ah
    Kim, Mi Na
    Lee, Yu Rim
    Hwang, Seong Gyu
    Rim, Kyu Sung
    Um, Soon Ho
    Tak, Won Young
    Kweon, Young Oh
    Park, Soo Young
    Kim, Seung Up
    [J]. JOURNAL OF VIRAL HEPATITIS, 2021, 28 (01) : 95 - 104
  • [8] Lower risk of hepatocellular carcinoma among patients with chronic hepatitis B treated with tenofovir than entecavir
    Young-Suk Lim
    [J]. Cancer Biology & Medicine, 2018, (S1) : 19 - 20
  • [9] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Jung Woo Shin
    Joonho Jeong
    Seok Won Jung
    Seung Bum Lee
    Bo Ryung Park
    Min-Ju Kim
    Eun Ji Park
    Neung Hwa Park
    [J]. Digestive Diseases and Sciences, 2021, 66 : 1739 - 1750
  • [10] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Shin, Jung Woo
    Jeong, Joonho
    Jung, Seok Won
    Lee, Seung Bum
    Park, Bo Ryung
    Kim, Min-Ju
    Park, Eun Ji
    Park, Neung Hwa
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1739 - 1750
12345